Diplomat Pharmacy, Inc. updating earnings guidance for the full year of 2019. For the year 2019, the company expects revenue between $4.7 and $5.0 billion. Net loss between $201 million and $191 million or diluted EPS between $2.69 and $2.55 compared to previous range of net loss $49 million and $33 million or diluted EPS between previous range of $0.65 and $0.44.